MedTrace Logo

Effects of the Consumption of Test Product on Urination in Healthy Japanese Adults

NCT07393126 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 76

Last updated 2026-02-06

No results posted yet for this study

Summary

The goal of this clinical trial is to test in Japanese adults who experience concerns regarding urinary frequency. The main question it aims to answer is:

•Does consumption of Cranberry Phospholipids reduce daytime urinary frequency?

Participants will be given the following tasks:

* Take two tablets daily containing Cranberry Phospholipid for eight weeks.
* Answer the questionnaire on the overactive bladder (OAB)-specific quality of life (QOL).
* Answer the questionnaire on OAB symptoms.
* Answer the questionnaire on urinary frequency during the study period. Researchers will compare Cranberry Phospholipids and placebo groups to see if Cranberry Phospholipids reduces daytime urinary frequency.

Conditions

  • Healthy Japanese

Interventions

DIETARY_SUPPLEMENT

Cranberry Phospholipids

Take two tablets will be taken once daily

DIETARY_SUPPLEMENT

Placebo

Take two tablets will be taken once daily

Sponsors & Collaborators

  • Orthomedico Inc.

    collaborator OTHER

  • Indena Japan Co. LTD

    collaborator UNKNOWN

  • Indena S.p.A

    lead INDUSTRY

Principal Investigators

  • Tsuyoshi Takara, MD · Medical Corporation Seishinkai, Takara Clinic

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2025-12-08
Primary Completion
2026-06-19
Completion
2026-06-19

Countries

  • Japan

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07393126 on ClinicalTrials.gov